Cu-Cyclam
Star0
Identification
- Generic Name
- Cu-Cyclam
- DrugBank Accession Number
- DB03189
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 263.87
Monoisotopic: 263.129697867 - Chemical Formula
- C10H24CuN4
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism ULysozyme C Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- LXENXYBNGDTDRA-UHFFFAOYSA-N
- InChI
- InChI=1S/C10H24N4.Cu/c1-3-11-7-9-13-5-2-6-14-10-8-12-4-1;/h11-14H,1-10H2;
- IUPAC Name
- 1,4,8,11-tetraazacyclotetradecane copper
- SMILES
- [Cu].C1CNCCNCCCNCCNC1
References
- General References
- Not Available
- External Links
- PDB Entries
- 1yik
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.294 mg/mL ALOGPS logP -0.66 ALOGPS logP -1.3 Chemaxon logS -2.8 ALOGPS pKa (Strongest Basic) 10 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 48.12 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 60.63 m3·mol-1 Chemaxon Polarizability 24.11 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9941 Blood Brain Barrier + 0.9596 Caco-2 permeable + 0.5147 P-glycoprotein substrate Substrate 0.6165 P-glycoprotein inhibitor I Non-inhibitor 0.6423 P-glycoprotein inhibitor II Non-inhibitor 0.8783 Renal organic cation transporter Inhibitor 0.6978 CYP450 2C9 substrate Non-substrate 0.8505 CYP450 2D6 substrate Non-substrate 0.6324 CYP450 3A4 substrate Non-substrate 0.6004 CYP450 1A2 substrate Non-inhibitor 0.7552 CYP450 2C9 inhibitor Non-inhibitor 0.8901 CYP450 2D6 inhibitor Non-inhibitor 0.8598 CYP450 2C19 inhibitor Non-inhibitor 0.8317 CYP450 3A4 inhibitor Non-inhibitor 0.9514 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7449 Ames test Non AMES toxic 0.5 Carcinogenicity Non-carcinogens 0.9422 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.5342 LD50, mol/kg Not applicable hERG inhibition (predictor I) Strong inhibitor 0.5265 hERG inhibition (predictor II) Non-inhibitor 0.7803
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsLysozyme C
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Lysozyme activity
- Specific Function
- Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents.
- Gene Name
- LYZ
- Uniprot ID
- P61626
- Uniprot Name
- Lysozyme C
- Molecular Weight
- 16536.885 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52